Previous Chapter Chapter 5: Pricing and Reimbursement Issues in Neurology Next Chapter

By: Decision Resources Inc

In: The SAGE Handbook of Healthcare

Chapter 5: Pricing and Reimbursement Issues in Neurology

  • Citations
  • Add to My List
  • Text Size

Pricing and Reimbursement Issues in Neurology
Pricing and reimbursement issues in neurology

Neurological disorders are common and highly disabling conditions that will impose a growing burden on aging societies in industrialized nations. We estimate that, in the United States, France, Germany, Italy, Spain, the United Kingdom, and Japan alone, the number of people afflicted with Alzheimer's disease, epilepsy, multiple sclerosis, and Parkinson's disease will increase from approximately 15 million in 2005 to 17 million in 2015. Spending on drug therapies for these four disorders will grow even faster, increasing from $11 billion in 2005 to $18 billion in 2015.

The size of this market is attributable in part to high drug prices, especially in the United States. The rising cost of routine poly-therapy and long-term use of ...

Looks like you do not have access to this content.


Don’t know how to login?

Click here for free trial login.

Back to Top

Copy and paste the following HTML into your website